CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 55 filers reported holding CYTEK BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,362,306 | -52.3% | 427,954 | -26.2% | 0.00% | -50.0% |
| Q2 2023 | $4,953,226 | +56508.3% | 580,003 | -39.1% | 0.00% | -60.0% |
| Q1 2023 | $8,750 | +535.9% | 952,175 | +606.7% | 0.01% | +400.0% |
| Q4 2022 | $1,376 | -100.0% | 134,730 | -67.0% | 0.00% | -75.0% |
| Q3 2022 | $6,013,000 | -37.9% | 408,459 | -54.7% | 0.00% | -33.3% |
| Q2 2022 | $9,684,000 | +662.5% | 902,482 | +666.3% | 0.01% | +500.0% |
| Q1 2022 | $1,270,000 | -66.9% | 117,774 | -34.2% | 0.00% | -50.0% |
| Q3 2021 | $3,832,000 | – | 178,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |